Skip to content
Search

Latest Stories

RPS England director Ravi Sharma resigns to take up top job at Luton & Dunstable University Hospital

The Royal Pharmaceutical Society (RPS) England director, Ravi Sharma, has resigned after four years on the job.

He will be leaving the RPS in October to join Luton and Dunstable University Hospital, part of the Bedfordshire Hospitals NHS Foundation Trust group, as head of pharmacy.


RPS will be commencing the recruitment of a new director for England shortly and in the interim Ravi will be working with Paul Bennett, the RPS CEO, to help in delivery of key objectives and in the appointment of his successor.

Paul commented: “Ravi has made a significant contribution to the organization during his time with us. His drive and enthusiasm for advancing the recognition of the role of the Society itself and of pharmacists and professional practice is probably best reflected by his desire to ensure a real focus on personalized medicines and his work on equality and diversity, workforce wellbeing, and most recently the development of a new vision for pharmacy in England.

"He has developed stronger relationships and collaborative working with Government, Department of Health and Social Care, NHS England, professional leadership bodies, organisations and patient groups over the years to support implementation of our policies and advocacy work.

“Ravi became a Fellow of the Society in 2022, in well-deserved recognition of his contribution to the profession and I know we can expect to see him remain close to the work of the RPS and a real advocate for the Society’s professional leadership role.

Ravi Sharma commented: "It’s been an honour and a privilege to lead the team in England at RPS on behalf of our members, and the wider profession.

“I want to pay tribute to the dedication of my colleagues who have been instrumental in supporting the profession through Covid-19, raising the profile of pharmacy with NHS leaders and politicians and bringing our strategy on inclusion and diversity to life.

“Our recent collaborative work on co-creating a vision for pharmacy in England will provide the profession with a blueprint for the future. This work will continue, I look forward to seeing it develop from my new vantage point within the NHS.

“Improving care for patients and the public through pharmacy remains my personal mission. I am hugely excited about the opportunity to work with the senior leadership team at Bedfordshire Hospitals NHS Foundation Trust. I am looking forward to putting theory into practice, working with the fantastic team who are delivering critical NHS hospital services.

“I’m very appreciative of the fantastic opportunities I’ve had at RPS and I am confident the organisation will continue to represent the best of pharmacy and professional leadership in the future.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less